Geri Care opens its 10th facility at Velachery: state-of-the-art Assisted Living for Elders with India's First Dialysis Day Care Centre
This newest 75-bed, state-of-the-art Assisted Living facility is designed for elders requiring expert medical care, including post-surgery recovery, chronic condition management, dementia care, and post-hospitalisation support. As part of this centre, Geri Care is introducing India's first Dialysis Day-care Centre for Elders that will spare families the strain of late-night treatments. Located in close proximity to the Geri Care Hospital, the facility also features a dedicated Elder Fitness Studio for physiotherapy and rehabilitation, along with beautifully landscaped Elder Grove spaces that encourage connection, relaxation, and rejuvenation for residents.
The facility was inaugurated by National Award-winning actor, acclaimed filmmaker, and philanthropist, Ms. Suhasini Maniratnam, whose unwavering commitment to social causes extends to championing dignified eldercare, and Padma Shri Prof. Dr. V.S. Natarajan, widely regarded as the 'Father of Geriatric Medicine in India' and a pioneer in shaping the country's approach to senior healthcare.
Speaking on the occasion, Dr. Lakshmipathy Ramesh, Founder & Managing Director of Geri Care Health Services said, 'This is a proud milestone for Geri Care. The launch of our state-of-the-art Assisted Living facility is where our vision meets the growing healthcare needs of India's elders. With over 10% of our population aged 60 and above, projected to nearly double by 2050; the demand for specialised eldercare has never been greater.'
He added, 'Our 10th facility at Velachery is designed to set new benchmarks. Our dialysis day-care centre, geriatric clinic, elder fitness studio, and physiotherapy services are all open to elders in the neighbourhood. Every detail serves one purpose -to make life healthier, easier, and more dignified. At Geri Care, our mission goes beyond healthcare; it's about giving elders a place where they feel cared for, respected, and valued every day.'
Inaugurating the facility, the Chief Guest, Ms. Suhasini Maniratnam said, 'Eldercare is a cause close to my heart, and Geri Care's work shows what true compassion in healthcare looks like. This facility is not just about medical support; it's about dignity, comfort, and giving our elders the quality of life they deserve.'
Guest of Honour, Padma Shri Prof. Dr. V.S. Natarajan in his inaugural remarks said, 'Specialised geriatric care is the need of the hour in our ageing nation. Geri Care's 360 degree approach is a model for the future, blending medical excellence with genuine respect for the elderly.'
About Geri Care:
Founded in 2018 by renowned geriatricians Dr. Lakshmipathy Ramesh & Dr. V. Srinivas, Geri Care is India's first integrated healthcare network exclusively serving senior citizens. Its comprehensive ecosystem spans personalized Home Care, Hospital Services, Assisted Living Centres, and Specialty Geriatric Clinics. Geri Care operates India's first multi-specialty hospitals dedicated to seniors and currently serves over 50,000 elders across multiple cities.
To learn more, visit www.gericare.in.
Photo: https://mma.prnewswire.com/media/2754344/Assisted_Living_Centre.jpgLogo: https://mma.prnewswire.com/media/2608690/5468683/Geri_Care_Logo.jpg
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
9 hours ago
- Malaysian Reserve
Geri Care opens its 10th facility at Velachery: state-of-the-art Assisted Living for Elders with India's First Dialysis Day Care Centre
CHENNAI, India, Aug. 20, 2025 /PRNewswire/ — Geri Care, India's pioneer in integrated eldercare, today announced the inauguration of its newest Assisted Living facility in Velachery, Chennai. This milestone marks Geri Care's 10th facility since inception in 2018, a testament to the organisation's rapid growth and unwavering dedication to transforming eldercare in India. This newest 75-bed, state-of-the-art Assisted Living facility is designed for elders requiring expert medical care, including post-surgery recovery, chronic condition management, dementia care, and post-hospitalisation support. As part of this centre, Geri Care is introducing India's first Dialysis Day-care Centre for Elders that will spare families the strain of late-night treatments. Located in close proximity to the Geri Care Hospital, the facility also features a dedicated Elder Fitness Studio for physiotherapy and rehabilitation, along with beautifully landscaped Elder Grove spaces that encourage connection, relaxation, and rejuvenation for residents. The facility was inaugurated by National Award-winning actor, acclaimed filmmaker, and philanthropist, Ms. Suhasini Maniratnam, whose unwavering commitment to social causes extends to championing dignified eldercare, and Padma Shri Prof. Dr. V.S. Natarajan, widely regarded as the 'Father of Geriatric Medicine in India' and a pioneer in shaping the country's approach to senior healthcare. Speaking on the occasion, Dr. Lakshmipathy Ramesh, Founder & Managing Director of Geri Care Health Services said, 'This is a proud milestone for Geri Care. The launch of our state-of-the-art Assisted Living facility is where our vision meets the growing healthcare needs of India's elders. With over 10% of our population aged 60 and above, projected to nearly double by 2050; the demand for specialised eldercare has never been greater.' He added, 'Our 10th facility at Velachery is designed to set new benchmarks. Our dialysis day-care centre, geriatric clinic, elder fitness studio, and physiotherapy services are all open to elders in the neighbourhood. Every detail serves one purpose -to make life healthier, easier, and more dignified. At Geri Care, our mission goes beyond healthcare; it's about giving elders a place where they feel cared for, respected, and valued every day.' Inaugurating the facility, the Chief Guest, Ms. Suhasini Maniratnam said, 'Eldercare is a cause close to my heart, and Geri Care's work shows what true compassion in healthcare looks like. This facility is not just about medical support; it's about dignity, comfort, and giving our elders the quality of life they deserve.' Guest of Honour, Padma Shri Prof. Dr. V.S. Natarajan in his inaugural remarks said, 'Specialised geriatric care is the need of the hour in our ageing nation. Geri Care's 360 degree approach is a model for the future, blending medical excellence with genuine respect for the elderly.' About Geri Care: Founded in 2018 by renowned geriatricians Dr. Lakshmipathy Ramesh & Dr. V. Srinivas, Geri Care is India's first integrated healthcare network exclusively serving senior citizens. Its comprehensive ecosystem spans personalized Home Care, Hospital Services, Assisted Living Centres, and Specialty Geriatric Clinics. Geri Care operates India's first multi-specialty hospitals dedicated to seniors and currently serves over 50,000 elders across multiple cities. To learn more, visit Photo:
Malaysian Reserve
16 hours ago
- Malaysian Reserve
Selonterra announces grant of United States patent on original discoveries in Alzheimer's disease
SAN MATEO, Calif., Aug. 19, 2025 /PRNewswire/ — Selonterra, Inc. ( a biotechnology company developing transformative therapies for neurodegenerative disorders announces that the U.S. Patent and Trademark Office (USPTO) has granted the U.S. Patent No. 12,385,093 entitled 'Use of APOE4 motif-mediated genes for diagnosis and treatment of Alzheimer's disease'. Selonterra focuses on neurodegenerative disorders with strong genetic links, including Alzheimer's disease (AD). APOE4 is the most important genetic factor associated with late onset AD. We discovered that the single nucleotide change in APOE4 regulates the expression of genes in its chromosomal vicinity. These APOE4-motif mediated genes offer novel unexploited targets for the development of small molecule therapeutics for AD. 'We relentlessly pursue intellectual property coverage along the entire development path from our early discoveries, through novel targets to small molecule composition of matter patents,' said Roman Urfer, PhD, Founder and CEO of Selonterra. 'The issuance of our patent around our newly discovered function of the APOE4 single nucleotide polymorphism is testament to our innovative strength,' said Anne Urfer-Buchwalder, PhD, Founder and President of Selonterra. 'These discoveries enable us to exploit the well-established APOE4 root cause of AD from a previously unappreciated angle.' About Selonterra, Inc. Selonterra, Inc. ( pursues transformative approaches to the development of therapies of neurodegenerative disorders, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. We harness human genetics, molecular pathway analysis and gene regulatory networks to identify proprietary disease-causing mechanisms and molecular targets, and exploit these to discover effective therapeutics. Selonterra's founders and advisors are scientists and executives with decades of biotech and pharma experience complemented by a global network of collaborator companies. Investor and Media Contact: T: (+1) 650 206 7025E: admin@
Malaysian Reserve
5 days ago
- Malaysian Reserve
Children's Hospital of Philadelphia and Children's Hospital Colorado Researchers Conduct First Prospective Study of Pediatric EoE Patients and Disease Progression
Study found that stiffness of the esophagus could serve as an important biomarker for disease progression and indicate which patients may benefit the most from current therapies PHILADELPHIA, Aug. 15, 2025 /PRNewswire/ — Researchers from Children's Hospital of Philadelphia (CHOP) and Children's Hospital Colorado have found that better control of chronic eosinophilic esophagitis (EoE)-associated inflammation during childhood leads to less stiffening of the esophagus, resulting in fewer disease complications. Using Endoluminal functional imaging (FLIP), the study team suggests this could be a key marker for assessing disease severity and progression. The findings were published online today by the journal Gastroenterology. EoE is a chronic allergic inflammatory disease of the esophagus, the muscular tube that carries food from the throat to the stomach. Children can experience nausea, regurgitation, vomiting, abdominal pain and a burning feeling like acid reflux. They may also have difficulty swallowing and gag frequently. Often, they can experience dysphagia, which is when it feels like something is stuck in their throat. If EoE goes untreated, the esophagus may narrow because of scarring, a phenomenon known as stricture. Chronic EoE-associated inflammation can lead to progressive tissue remodeling and fibrostenosis, or the narrowing of the esophagus. While clinicians recognize the severity of the disease, long-term studies looking at disease progression over time, and the impact of controlling the disease from a young age, is relatively unknown. 'This is the first study to follow kids overtime (with these endoscopic assessments) and evaluate the patients who are at the highest risk of complications,' said co-senior study author Amanda Muir, MD, a pediatric gastroenterologist in the Division of Gastroenterology, Hepatology and Nutrition at CHOP. 'With the recent FDA approval of two medications for EoE, having this data could help identify the patients who could benefit from these therapies the most and observe improvement at a histologic level over time.' Researchers at CHOP and Children's Hospital Colorado launched a longitudinal study to evaluate long-term changes in esophageal distensibility, or the ability of the esophagus to expand, in pediatric patients between the ages of 3 and 18 years old. Symptomatic, endoscopic and histologic data were collected at each visit during the study. A total of 112 patients with EoE were included with a median follow-up time of 11 months, some followed for over 4 years. 'Following children living with EoE over time has given us a clearer picture of how inflammation affects the esophagus and how treating it can improve the esophagus and outcomes for patients,' said Calies Menard-Katcher, MD, co-senior study author and Associate Director of Clinical Research for the Gastrointestinal Eosinophilic Diseases Program at Children's Hospital Colorado. 'It's exciting to see these results confirm what we've suspected in caring for patients — and they may even help us spot those at risk for more severe disease.' The study found that patients with tissue samples showing a response to treatment demonstrated the most improvement in distensibility over time. After adjusting for different factors, the study found that patients with lower esophageal distensibility had increased odds of patient-reported dysphagia, or difficulty swallowing. Patients with fibrostenosis were generally diagnosed at an older age, had the disease for a longer period and showed reduced esophageal distensibility at baseline predicted the need for future dilation in patients with strictures. The authors suggest that further studies that examine the disease from a molecular level could help them understand which patients may be at highest risk of severe disease and could benefit from a variety of treatment strategies. This study was supported by the National Institutes of Health grants R01DK124266-01, K23DK109263 and R21TR003039. Kennedy et al, 'Histologic response is associated with improved esophageal distensibility and symptom burden in pediatric eosinophilic esophagitis.' Gastroenterology. Online August 15, 2025. DOI: 10.1053/ About Children's Hospital of Philadelphia:A non-profit, charitable organization, Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, the hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. The institution has a well-established history of providing advanced pediatric care close to home through its CHOP Care Network, which includes more than 50 primary care practices, specialty care and surgical centers, urgent care centers, and community hospital alliances throughout Pennsylvania and New Jersey. CHOP also operates the Middleman Family Pavilion and its dedicated pediatric emergency department in King of Prussia, the Behavioral Health and Crisis Center (including a 24/7 Crisis Response Center) and the Center for Advanced Behavioral Healthcare, a mental health outpatient facility. Its unique family-centered care and public service programs have brought Children's Hospital of Philadelphia recognition as a leading advocate for children and adolescents. For more information, visit ABOUT CHILDREN'S HOSPITAL COLORADO Children's Hospital Colorado is one of the nation's leading and most expansive nonprofit pediatric healthcare systems with a mission to improve the health of children through patient care, education, research and advocacy. Founded in 1908 and ranked among the best children's hospitals in the nation as recognized by U.S. News & World Report, Children's Colorado has established itself as a pioneer in the discovery of innovative and groundbreaking treatments that are shaping the future of pediatric healthcare worldwide. Children's Colorado offers a full spectrum of family-centered care at its urgent, emergency and specialty care locations throughout Colorado, including an academic medical center on the Anschutz Medical Campus in Aurora, hospitals in Colorado Springs, Highlands Ranch and Broomfield, and outreach clinics across the region. For more information, visit or connect with us on Facebook, Instagram and YouTube. Contact: Ben LeachChildren's Hospital of Philadelphia(609)634-7906leachb@
